Table 2 Propensity score matching quality
Unmached | Propensity score matched groups | |||||||
|---|---|---|---|---|---|---|---|---|
Full sample | Full | Male | Female | White | Black | Hispanic | Other | |
Baseline Age | 40.39 | -11.73 | -4.06 | -12.81 | -12.10 | -10.95 | -2.21 | -8.98 |
Male | -44.56 | -7.27 | N.A. | N.A. | -7.45 | -6.57 | 0.99 | -5.20 |
White | -5.41 | 7.79 | 14.19 | 6.50 | N.A. | |||
Black | 8.25 | -2.84 | -4.69 | -3.82 | ||||
Hispanic | -3.67 | -5.42 | -7.12 | -6.94 | ||||
Other | 2.26 | -4.08 | -8.42 | -0.92 | ||||
Ever Dual Eligible | 1.43 | -12.25 | -23.02 | -17.09 | -13.25 | -6.88 | < 0.01 | -7.64 |
Yearly Trend (2000 = 0) | -43.90 | -17.27 | -21.66 | -20.49 | -19.36 | -15.31 | 0.17 | -11.81 |
Congestive heart failure | 36.45 | -6.84 | -10.62 | -7.02 | -9.10 | -3.87 | -3.12 | -7.81 |
Cardiac arrhythmias | 55.23 | -7.24 | -5.08 | -7.22 | -7.96 | -4.21 | 8.98 | -6.39 |
Valvular disease | 35.79 | -5.02 | -3.03 | -4.25 | -6.67 | -1.75 | -3.93 | -6.49 |
Pulmonary circulation Disorders | 20.09 | -2.68 | -3.09 | -2.95 | -3.06 | 0.90 | 4.78 | -2.58 |
Peripheral vascular disorders | 31.67 | -6.75 | -10.37 | -8.02 | -7.18 | -3.62 | -5.55 | < 0.01 |
Hypertension, uncomplicated | 53.70 | -6.19 | -4.67 | -4.90 | -7.49 | 1.37 | -6.76 | 2.93 |
Hypertension, complicated | 32.61 | -3.67 | -9.17 | -5.23 | -5.72 | -4.18 | -4.29 | -7.09 |
Paralysis | 8.16 | -2.36 | -3.39 | -2.76 | -4.27 | 0.00 | 8.60 | 0.00 |
Other neurological disorders | 17.38 | -2.76 | -5.03 | -4.51 | -6.36 | -1.38 | 3.94 | -5.37 |
Chronic pulmonary disease | 35.08 | -8.59 | -13.86 | -7.85 | -11.83 | -3.52 | 0.95 | -3.70 |
Diabetes, uncomplicated | 25.24 | -7.36 | -9.51 | -8.71 | -8.42 | -4.10 | -9.19 | -6.74 |
Diabetes, complicated | 21.13 | -4.02 | -7.58 | -5.61 | -5.97 | 0.28 | -1.17 | -8.16 |
Hypothyroidism | 90.71 | 6.23 | -0.40 | 6.46 | 6.61 | 2.21 | -2.71 | 3.50 |
Renal failure | 22.93 | -3.09 | -7.93 | -5.09 | -3.71 | -2.41 | -8.95 | -7.36 |
Liver disease | 16.80 | -3.87 | -3.73 | -3.50 | -3.98 | -2.30 | -3.18 | 0.45 |
Peptic ulcer disease excluding bleeding | 13.68 | -1.83 | -2.57 | -2.00 | -3.21 | -1.89 | -1.86 | -1.98 |
AIDS/H1V | -0.05 | -1.29 | -3.26 | -1.89 | -2.36 | 6.40 | < 0.01 | 4.59 |
Lymphoma | 6.64 | -1.61 | -1.53 | -2.97 | -3.05 | -2.91 | < 0.01 | 5.59 |
Metastatic cancer | 10.51 | -1.92 | -5.92 | -0.91 | -4.73 | -5.47 | 5.44 | < 0.01 |
Solid tumor without metastasis | 25.60 | -4.74 | -3.73 | -3.88 | -5.82 | -8.01 | -1.57 | 1.61 |
Rheumatoid arthritis/ collagen vascular diseases | 25.60 | -2.91 | -2.78 | -2.43 | -2.18 | -4.09 | 9.34 | 1.27 |
Coagulopathy | 21.35 | -3.12 | -2.94 | -3.65 | -3.27 | -0.26 | 1.93 | -6.30 |
Obesity | 14.35 | -3.60 | -7.12 | -4.13 | -4.85 | 2.11 | -1.50 | -1.13 |
Weight loss | 37.93 | -2.12 | -3.19 | -4.27 | -2.32 | -3.24 | < 0.01 | -3.42 |
Fluid and electrolyte disorders | 38.26 | -4.50 | -7.95 | -6.81 | -7.36 | -4.33 | -5.46 | -1.85 |
Blood loss anemia | 15.78 | -0.13 | -0.89 | -0.90 | -2.00 | -1.91 | 11.00 | < 0.01 |
Deficiency anemia | 31.46 | -2.89 | -3.41 | -5.87 | -3.54 | -2.77 | 5.73 | -3.48 |
Alcohol abuse | 1.83 | -3.95 | -4.95 | -3.85 | -3.97 | -1.68 | < 0.01 | 1.53 |
Drug abuse | 5.42 | -1.59 | -1.85 | -1.85 | -2.50 | -2.62 | -5.44 | < 0.01 |
Psychoses | 7.48 | -3.63 | -7.35 | -3.54 | -4.12 | -1.36 | < 0.01 | -1.89 |
Depression | 26.35 | -5.29 | -7.49 | -7.14 | -7.67 | -3.69 | 1.29 | < 0.01 |
N | 3,399,925 | 39,596 | 8,466 | 31,068 | 32,976 | 3,916 | 452 | 1,896 |
N Graves Disease | 19,852 | 19,798 | 4,233 | 15,534 | 16,488 | 1,958 | 226 | 948 |
N Alzheimer’s Disease | 320,508 | 3,846 | 646 | 3,306 | 3,238 | 437 | 52 | 174 |